NCT02956382 2025-07-18Ibrutinib and Venetoclax in Relapsed and Refractory Follicular LymphomaGeorgetown UniversityPhase 1/2 Completed24 enrolled 18 charts
NCT04070768 2025-05-04Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113Big Ten Cancer Research ConsortiumPhase 1 Completed18 enrolled 15 charts